Loading...
DOCUMENTS
80
NOTICES
153
MOTS CLES
Access to care
Treatment
Anti-HCV Direct Acting Antivirals DAA
Axial spondyloarthritis
Ankylosing
Adverse side effects
Anxiété
Antibiotics
Apremilast
Sacroiliitis
Antimicrobiens
Beta-lactam antibiotics
Intensive care
Cancer
Immunotherapy
Drug survival
Biological therapy
Acute Myeloid Leukaemia AML
Biologic therapy
Dermatology
Glucocorticoids
Anticancer drugs
Immune checkpoint inhibitors
Angiotensin receptor blockers
ArtThese
Biologic
Adalimumab
Graft-versus-host disease
Psoriasis
Alitretinoin
Méta-Analyse
Alcohol
Aging
Atrial fibrillation
Pharmacoepidemiology
Quality of life
Infliximab
Stability
Primary adrenal insufficiency
Calcium channel blockers
BTK protein
Cardiovascular therapy
CTLA-4
Ethics
Biologic drug
Amyloidosis
Adolescent
Arthritis
Atopic dermatitis
Case-Control Studies
Antimicrobial resistance
Autoimmunity
Sipuleucel-T
Ustekinumab
Biomarkers
Burden
Arrhythmia
Antimicrobials
Biosimilar Pharmaceuticals
Autoimmune diseases
Azathioprine
Auto-Diagnostic
Care pathway
Vigibase®
Cardiotoxicity
Abus d'antibiotiques
Apre-milast
Cattle
Placebo
Angiotensin-converting enzyme inhibitors
Psoriatic arthritis
Management
Biological Therapy
Anxiety
CSK tyrosine-protein kinase
Pharmacovigilance
Biologics
COVID-19
Epidemiology
Albinism
Auto-immune hepatitis
Biomédicaments
Drug reaction
Meta-Analysis
Etanercept
Immune-related adverse events
Bacterial rhinosinusitis
Antibiotic resistance
ASDAS
Cardiovascular risk
Anti-TNF
Cardiomyopathy
Accelerometer
Endocrine toxicity
Cardio-oncology
Ankylosing spondylitis
Antibiotic misuse
Prostate cancer
Addiction
Spondyloarthritis
Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379 | |
---|---|
Adresse |
Université Paris-Est Créteil Val de Marne (UPEC) Campus Centre de Créteil |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Émilie SBIDIAN |
Axe(s) de recherche
|
|
COLLABORATIONS
|